Launched in 2006, Chiratae Ventures India Advisors a home grown early-stage tech Venture Capital Fund backing stellar entrepreneurs disrupting or creating new ecosystems, the fund has been an early backer of Curefit, Firstcry, GlobalBees, Lenskart, and Myntra, and has invested in leaders like AgroStar, Bizongo, Bounce, Cropin, EarlySalary, GoMechanic, HealthifyMe, NestAway, Pyxis, Uniphore, Vayana, amongst others. In its 16th year of existence, it closed its fourth fund oversubscribed at $337 million in 2021. Through the years, the team has delivered value for its investors with over 40 exits and driven portfolio growth as demonstrated by $1 billion AUM since its inception, 3 IPOs and 8 Unicorns, with more round the corner.

The Global Advisory Board of Chiratae Ventures comprises of Mr. Ratan Tata - Chairman Emeritus of Tata Sons, Mr. Kris Gopalakrishnan - Former Vice Chairman & Founder of Infosys, Mr. Manish Choksi - Non-Executive Vice Chairman of Asian Paints, Mr. Bruno Raschle - Founder, Managing Director, & Non-Executive Vice Chairman of Schroder Adveq, Dr. Andreas Hettich - Chair of Hettich Group Advisory Board and the India advisory board comprises of Dr. Ferzaan Engineer - Co-founder and Chairman of Cytecare Hospitals. They bring decades of experience in running successful organisations across the world and assist us and our entrepreneurs in their journey of building lasting organisations.

To know more, refer to - Chiratae Ventures or email us at sonic@chiratae.com